September 29, 2022 Comments Off on New patent for Amgen Inc drug LUMAKRAS Posted in: Patent Added Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWatch…
September 29, 2022 Comments Off on Pharmaceutical companies with the most orphan drugs Posted in: Infographic Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
